在患有囊性纤维化的人中,CFTR调节器诱导的汗液化物度的异质性
E T Zemanick1, I Emerman2, M McCreary2
1University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
概括
囊性纤维化 (CF) 患者在CF跨膜导电调节器 (CFTR) 调节器上显示出不同的汗液化物水平. 一些基因型仍然具有高水平,表明可以改进CFTR恢复疗法.
科学领域:
- 生物医学研究的研究.
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
背景情况:
- 在患有囊性纤维化 (PwCF) 的人群中,汗液化物 (SC) 度与CF跨膜导电调节器 (CFTR) 蛋白功能相关.
- 较高的SC水平通常表明CFTR功能较低,疾病更严重.
- CFTR调节器疗法可以改善CFTR功能并减少SC,但水平可能不会正常化.
研究的目的:
- 分析PwCF中后调节器SC度的可变性.
- 评估基于CFTR调节器类型和患者基因型的SC度差异.
主要方法:
- 从3131个PwCF中收集了SC测量结果,这些PwCF被调节器治疗了至少90天.
- 利用图表审查和CF基金会患者登记 (CFFPR) 的临床数据.
- 使用累积频率分布评估SC度变化.
主要成果:
- 分析了调节后的SC度 (n=3787),其中大多数 (47%) 来自elexacaftor/tezacaftor/ivacaftor (ETI) 治疗.
- 调节器使用降低了SC分布,ETI显示了最低的平均度.
- 虽然79%的后ETI SC是<60 mmol/L和26%<30 mmol/L,但基因型的显著变异性仍然存在,F508del/最小功能基因型显示最高比例 (31%) 的SC≥60 mmol/L.
结论:
- 后调节器SC度的异质性存在于包括ETI在内的基因型和调节器中.
- 在CF诊断范围内的SC度的持久性表明通过额外的疗法进一步恢复CFTR的潜力.
更多相关视频
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.7K
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
19.3K
相关概念视频
01:23Cystic Fibrosis: Pathogenesis
241
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
241
01:24Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164